本篇報(bào)告共?135?頁，為保障社群會員權(quán)益，僅展示前?68?頁；成為會員后可無限制下載原報(bào)告與歷史更新報(bào)告，以及每日更新100+。目前已累積更新80000+。

這是全行業(yè)報(bào)告圈的第1176期分享

來源?/ DEEP PHARMA INTELLIGENCE

本篇摘要

This 135page "Artificial Intelligence for Drug Discovery Landscape Overview Q3 2022"report represents the eleventh issue of market analytics focused on the Artificial Intelligence(Al) application in the pharmaceutical research industry.
The primary goal of this series of reports is to give a complete picture of the industry environment in terms of Al usage in drug discovery, clinical research, and other elements of pharmaceutical research and development.?
This overview highlights recent trends and insights in the form of helpful mind maps and infographics and gauges the performance of prominent players who shape the industry's space and relationships.?
It can help the reader comprehend what is going on in the sector and potentially predict what will happen next Since the last edition, data has been significantly updated to reflect the fast-paced market dynamics and an overall increase in pharmaceutical Al investment and business development activities.
The listings of Al-biotech businesses, biotech investors, and pharmaceutical organizations have been expanded to reflect the pharmaceutical industry's rising interest in sophisticated data analytics technology.
Alongside investment and business trends, the report also provides technical insights into some of the latest Al applications and research achievements.

報(bào)告前68頁預(yù)覽

篇幅有限，以上為本篇部分內(nèi)容，喜歡本期內(nèi)容可以點(diǎn)贊評論

免責(zé)聲明

本平臺只做內(nèi)容的收集及分享，報(bào)告版權(quán)歸原撰寫發(fā)布機(jī)構(gòu)所有，由全行業(yè)報(bào)告圈社群朋友通過公開合法渠道獲得，如涉及侵權(quán)，請聯(lián)系我們刪除；如對報(bào)告內(nèi)容存疑，請與撰寫、發(fā)布機(jī)構(gòu)聯(lián)系。? ?